Mythic Therapeutics Appoints George Eliades, Ph.D., As President and Chief Executive Officer (CEO)

Mar 28, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Mythic Therapeutics

George Eliades

WalthamBiotechnology

Description

Mythic Therapeutics has announced the appointment of George Eliades, Ph.D., as the President and Chief Executive Officer (CEO). Dr. Eliades brings extensive experience in corporate strategy, business development, and launching innovative medicines in oncology from his previous role at Jazz Pharmaceuticals.

Company Information

Company

Mythic Therapeutics

Location

Waltham, Massachusetts, United States

About

Mythic Therapeutics is a product-platform company developing a pipeline of antibody-drug conjugates (ADCs) designed to exhibit unparalleled therapeutic index and efficacy. The Company’s FateControl technology specifically enhances ADC uptake in targeted tissues by manipulating the fate of the ADC within the cell, thereby expanding the disease and patient profiles that can be treated with Mythic’s ADCs.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months